Assessing the impact of the Inflation Reduction Act on Medicare prescription drug coverage
Medicare Part D plans in 2025 were strategically designed to increase beneficiaries' financial responsibilities via higher deductibles, increased co-insurance cost sharing, and restricted formulary coverage. While overall annual patient medication cost burdens will decrease, the cost of filling each medication will increase, which may negatively impact medication access and adherence.
Authors
- Xu Guo (ORCID: https://orcid.org/0000-0001-5942-325X)
- Yi Wolf Zhang (ORCID: https://orcid.org/0000-0001-8341-0539)
- Michael G. Blyumin
- Minlu Zhang
- Cori Qu
Institutions
- Stanford Health Care (US)
- Stanford Medicine (US)
- Center for Innovation (US)
Publication Details
- Journal
- American Journal of Health-System Pharmacy
- Published
- 2026-03-07
- DOI
- https://doi.org/10.1093/ajhp/zxag083
- Primary Topic
- Medication Adherence and Compliance
- Type
- article
- Field-Weighted Citation Impact
- 0.00